5 May 2023
Pharmaceuticals | Top 5 Selected Papers in 2021–2022 in the Section “Natural Products”
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
1. “Benefits of Ginger and Its Constituent 6-Shogaol in Inhibiting Inflammatory Processes”
by Iris Bischoff-Kont and Robert Fürst
Pharmaceuticals 2021, 14(6), 571; https://doi.org/10.3390/ph14060571
Available online: https://www.mdpi.com/1424-8247/14/6/571
2. “New Insights into Curcumin- and Resveratrol-Mediated Anti-Cancer Effects”
by Andrea Arena, Maria Anele Romeo, Rossella Benedetti, Laura Masuelli, Roberto Bei, Maria Saveria Gilardini Montani and Mara Cirone
Pharmaceuticals 2021, 14(11), 1068; https://doi.org/10.3390/ph14111068
Available online: https://www.mdpi.com/1424-8247/14/11/1068
3. “Ursolic Acid Inhibits Collective Cell Migration and Promotes JNK-Dependent Lysosomal Associated Cell Death in Glioblastoma Multiforme Cells”
by Gillian E. Conway, Deimante Zizyte, Julie Rose Mae Mondala, Zhonglei He, Lorna Lynam, Mathilde Lecourt, Carlos Barcia, Orla Howe and James F. Curtin
Pharmaceuticals 2021, 14(2), 91; https://doi.org/10.3390/ph14020091
Available online: https://www.mdpi.com/1424-8247/14/2/91
4. “In Silico and In Vitro Identification of Pan-Coronaviral Main Protease Inhibitors from a Large Natural Product Library”
by Nasim Shahhamzehei, Sara Abdelfatah and Thomas Efferth
Pharmaceuticals 2022, 15(3), 308; https://doi.org/10.3390/ph15030308
Available online: https://www.mdpi.com/1424-8247/15/3/308
5. “Immunomodulatory and Antiaging Mechanisms of Resveratrol, Rapamycin, and Metformin: Focus on mTOR and AMPK Signaling Networks”
by Vincenzo Sorrenti, Francesca Benedetti, Alessandro Buriani, Stefano Fortinguerra, Giada Caudullo, Sergio Davinelli, Davide Zella and Giovanni Scapagnini
Pharmaceuticals 2022, 15(8), 912; https://doi.org/10.3390/ph15080912
Available online: https://www.mdpi.com/1424-8247/15/8/912